Thus, IGF targeting was shown to alter the tumor immune ME in colon cancer, reducing anti-inflammatory cytokines [106] and our own data identified IGF-IR on neutrophils and HSCs as a contributor to liver metastasis [109,110]. Here, IGF1R is linked to malignant colon neoplasm.